Global Halitosis Treatment

Halitosis Treatment Comprehensive Study by Type (Pathological, Non-pathological), Application (Lungs, Liver, Respiratory, Systemic, Gastrointestinal, Others), Diagnostic Tests (Gas chromatography, Halimeter, Beta-galactosidase activity assay, Others), Distribution Channel (Dental Hospitals, Dental Clinics, Retail Pharmacies, Online Pharmacies), Drug Treatment (Antiseptic, Antacids, Ranitidine, Others) Players and Region - Global Market Outlook to 2029

Halitosis Treatment Market by XX Submarkets | Forecast Years 2024-2029  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Halitosis Treatment?
Halitosis is a clinical disorder characterized by an unpleasant odor present in the mouth. It has evolved into a global social issue that affects a significant number of people. The most common causes of halitosis are poor oral hygiene and a lack of knowledge about the disease's diagnosis. Because of the broad variety of dental health care products available, the growing geriatric population, and the rising prevalence of periodontal diseases, the halitosis treatment market is expected to expand significantly. Diet, medication, poor health hygiene, asthma, GERD, lactose intolerance, and gum diseases are all factors that contribute to the condition. It is a big problem all over the world, with a high prevalence of mild halitosis but just 5% of the population suffering from serious cases. The demand is being boosted by an increase in the number of people suffering from halitosis, as well as increased understanding of the disease and its treatment.Tobacco and alcohol intake are two main factors that contribute to halitosis. It can cause stress and psychological strain, which can have a detrimental effect on a person's life. For the treatment of halitosis, a variety of oral care products are available. Oral care products are being manufactured in a variety of flavours by major market players in order to draw more consumers while retaining product consistency.

AttributesDetails
Study Period2019-2029
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledColgate-Palmolive Company (United States), All USA Partners LLC (United States), Dr. Harold Katz, LLC (United States), Listerine (United States), AstraZeneca (United Kingdom), Unilever (United Kingdom), Oral B (United States), Philips oral healthcare (United States) and Roche (Switzerland)


The study covers a detailed analysis segmented by key business segments i.e. by type (Pathological and Non-pathological) , by application (Lungs, Liver, Respiratory, Systemic, Gastrointestinal and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Halitosis Treatment market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Halitosis Treatment market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Colgate-Palmolive Company (United States), All USA Partners LLC (United States), Dr. Harold Katz, LLC (United States), Listerine (United States), AstraZeneca (United Kingdom), Unilever (United Kingdom), Oral B (United States), Philips oral healthcare (United States) and Roche (Switzerland).

Market Overview:
In August 2021, Alphabet company, and Colgate-Palmolive, the global leader in oral care, today announced a strategic collaboration to advance oral health research. Under the agreement, Colgate's Dental Clinical Team will partner with Verily to conduct an innovative oral health study as part of Verily’s ongoing Baseline Health Study that will aim to improve understanding of connections between oral health and overall human health.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Influencing Trend:
Growing Use of Various Oral Care Products Such As Mouth Washes, Toothpastes, and Mouth Sprays

Market Growth Drivers:
Increasing Incidents of Dental Problems and Surge in Geriatric Population Suffering From These Diseases

Challenges:
Lack of Awareness Among Population of Emerging Economies

Restraints:
High Treatment Cost

Opportunities:
Increased Investment in Healthcare Industry

Key highlights of the Global Halitosis Treatment market Study:
• CAGR of the market during the forecast period 2023-2029
• In-depth information on growth factors that will accelerate the Halitosis Treatment market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global Halitosis Treatment market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Halitosis Treatment Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Halitosis Treatment market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Halitosis Treatment market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Pharmaceutical Industry, Healthcare Industry, Regulatory Bodies and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Pathological
  • Non-pathological
By Application
  • Lungs
  • Liver
  • Respiratory
  • Systemic
  • Gastrointestinal
  • Others
By Diagnostic Tests
  • Gas chromatography
  • Halimeter
  • Beta-galactosidase activity assay
  • Others

By Distribution Channel
  • Dental Hospitals
  • Dental Clinics
  • Retail Pharmacies
  • Online Pharmacies

By Drug Treatment
  • Antiseptic
  • Antacids
  • Ranitidine
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidents of Dental Problems
      • 3.2.2. Surge in Geriatric Population Suffering From These Diseases
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness Among Population of Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Growing Use of Various Oral Care Products Such As Mouth Washes, Toothpastes, and Mouth Sprays
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Halitosis Treatment, by Type, Application, Diagnostic Tests, Distribution Channel, Drug Treatment and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Halitosis Treatment (Value)
      • 5.2.1. Global Halitosis Treatment by: Type (Value)
        • 5.2.1.1. Pathological
        • 5.2.1.2. Non-pathological
      • 5.2.2. Global Halitosis Treatment by: Application (Value)
        • 5.2.2.1. Lungs
        • 5.2.2.2. Liver
        • 5.2.2.3. Respiratory
        • 5.2.2.4. Systemic
        • 5.2.2.5. Gastrointestinal
        • 5.2.2.6. Others
      • 5.2.3. Global Halitosis Treatment by: Diagnostic Tests (Value)
        • 5.2.3.1. Gas chromatography
        • 5.2.3.2. Halimeter
        • 5.2.3.3. Beta-galactosidase activity assay
        • 5.2.3.4. Others
      • 5.2.4. Global Halitosis Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Dental Hospitals
        • 5.2.4.2. Dental Clinics
        • 5.2.4.3. Retail Pharmacies
        • 5.2.4.4. Online Pharmacies
      • 5.2.5. Global Halitosis Treatment by: Drug Treatment (Value)
        • 5.2.5.1. Antiseptic
        • 5.2.5.2. Antacids
        • 5.2.5.3. Ranitidine
        • 5.2.5.4. Others
      • 5.2.6. Global Halitosis Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Halitosis Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Colgate-Palmolive Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. All USA Partners LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Dr. Harold Katz, LLC (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Listerine (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Unilever (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Oral B (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Philips oral healthcare (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roche (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Halitosis Treatment Sale, by Type, Application, Diagnostic Tests, Distribution Channel, Drug Treatment and Region (value) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global Halitosis Treatment (Value)
      • 7.2.1. Global Halitosis Treatment by: Type (Value)
        • 7.2.1.1. Pathological
        • 7.2.1.2. Non-pathological
      • 7.2.2. Global Halitosis Treatment by: Application (Value)
        • 7.2.2.1. Lungs
        • 7.2.2.2. Liver
        • 7.2.2.3. Respiratory
        • 7.2.2.4. Systemic
        • 7.2.2.5. Gastrointestinal
        • 7.2.2.6. Others
      • 7.2.3. Global Halitosis Treatment by: Diagnostic Tests (Value)
        • 7.2.3.1. Gas chromatography
        • 7.2.3.2. Halimeter
        • 7.2.3.3. Beta-galactosidase activity assay
        • 7.2.3.4. Others
      • 7.2.4. Global Halitosis Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Dental Hospitals
        • 7.2.4.2. Dental Clinics
        • 7.2.4.3. Retail Pharmacies
        • 7.2.4.4. Online Pharmacies
      • 7.2.5. Global Halitosis Treatment by: Drug Treatment (Value)
        • 7.2.5.1. Antiseptic
        • 7.2.5.2. Antacids
        • 7.2.5.3. Ranitidine
        • 7.2.5.4. Others
      • 7.2.6. Global Halitosis Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Halitosis Treatment: by Type(USD Million)
  • Table 2. Halitosis Treatment Pathological , by Region USD Million (2018-2023)
  • Table 3. Halitosis Treatment Non-pathological , by Region USD Million (2018-2023)
  • Table 4. Halitosis Treatment: by Application(USD Million)
  • Table 5. Halitosis Treatment Lungs , by Region USD Million (2018-2023)
  • Table 6. Halitosis Treatment Liver , by Region USD Million (2018-2023)
  • Table 7. Halitosis Treatment Respiratory , by Region USD Million (2018-2023)
  • Table 8. Halitosis Treatment Systemic , by Region USD Million (2018-2023)
  • Table 9. Halitosis Treatment Gastrointestinal , by Region USD Million (2018-2023)
  • Table 10. Halitosis Treatment Others , by Region USD Million (2018-2023)
  • Table 11. Halitosis Treatment: by Diagnostic Tests(USD Million)
  • Table 12. Halitosis Treatment Gas chromatography , by Region USD Million (2018-2023)
  • Table 13. Halitosis Treatment Halimeter , by Region USD Million (2018-2023)
  • Table 14. Halitosis Treatment Beta-galactosidase activity assay , by Region USD Million (2018-2023)
  • Table 15. Halitosis Treatment Others , by Region USD Million (2018-2023)
  • Table 16. Halitosis Treatment: by Distribution Channel(USD Million)
  • Table 17. Halitosis Treatment Dental Hospitals , by Region USD Million (2018-2023)
  • Table 18. Halitosis Treatment Dental Clinics , by Region USD Million (2018-2023)
  • Table 19. Halitosis Treatment Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 20. Halitosis Treatment Online Pharmacies , by Region USD Million (2018-2023)
  • Table 21. Halitosis Treatment: by Drug Treatment(USD Million)
  • Table 22. Halitosis Treatment Antiseptic , by Region USD Million (2018-2023)
  • Table 23. Halitosis Treatment Antacids , by Region USD Million (2018-2023)
  • Table 24. Halitosis Treatment Ranitidine , by Region USD Million (2018-2023)
  • Table 25. Halitosis Treatment Others , by Region USD Million (2018-2023)
  • Table 26. South America Halitosis Treatment, by Country USD Million (2018-2023)
  • Table 27. South America Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 28. South America Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 29. South America Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 30. South America Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 31. South America Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 32. Brazil Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 33. Brazil Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 34. Brazil Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 35. Brazil Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 36. Brazil Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 37. Argentina Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 38. Argentina Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 39. Argentina Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 40. Argentina Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 41. Argentina Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 42. Rest of South America Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 43. Rest of South America Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 44. Rest of South America Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 45. Rest of South America Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 46. Rest of South America Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 47. Asia Pacific Halitosis Treatment, by Country USD Million (2018-2023)
  • Table 48. Asia Pacific Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 49. Asia Pacific Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 50. Asia Pacific Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 51. Asia Pacific Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 52. Asia Pacific Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 53. China Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 54. China Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 55. China Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 56. China Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 57. China Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 58. Japan Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 59. Japan Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 60. Japan Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 61. Japan Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 62. Japan Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 63. India Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 64. India Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 65. India Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 66. India Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 67. India Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 68. South Korea Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 69. South Korea Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 70. South Korea Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 71. South Korea Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 72. South Korea Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 73. Taiwan Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 74. Taiwan Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 75. Taiwan Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 76. Taiwan Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 77. Taiwan Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 78. Australia Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 79. Australia Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 80. Australia Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 81. Australia Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 82. Australia Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 87. Rest of Asia-Pacific Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 88. Europe Halitosis Treatment, by Country USD Million (2018-2023)
  • Table 89. Europe Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 90. Europe Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 91. Europe Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 92. Europe Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 93. Europe Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 94. Germany Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 95. Germany Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 96. Germany Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 97. Germany Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 98. Germany Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 99. France Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 100. France Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 101. France Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 102. France Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 103. France Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 104. Italy Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 105. Italy Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 106. Italy Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 107. Italy Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 108. Italy Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 109. United Kingdom Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 110. United Kingdom Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 111. United Kingdom Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 112. United Kingdom Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 113. United Kingdom Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 114. Netherlands Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 115. Netherlands Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 116. Netherlands Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 117. Netherlands Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 118. Netherlands Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 119. Rest of Europe Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 120. Rest of Europe Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 121. Rest of Europe Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 122. Rest of Europe Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 123. Rest of Europe Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 124. MEA Halitosis Treatment, by Country USD Million (2018-2023)
  • Table 125. MEA Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 126. MEA Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 127. MEA Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 128. MEA Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 129. MEA Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 130. Middle East Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 131. Middle East Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 132. Middle East Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 133. Middle East Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 134. Middle East Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 135. Africa Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 136. Africa Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 137. Africa Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 138. Africa Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 139. Africa Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 140. North America Halitosis Treatment, by Country USD Million (2018-2023)
  • Table 141. North America Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 142. North America Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 143. North America Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 144. North America Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 145. North America Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 146. United States Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 147. United States Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 148. United States Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 149. United States Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 150. United States Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 151. Canada Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 152. Canada Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 153. Canada Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 154. Canada Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 155. Canada Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 156. Mexico Halitosis Treatment, by Type USD Million (2018-2023)
  • Table 157. Mexico Halitosis Treatment, by Application USD Million (2018-2023)
  • Table 158. Mexico Halitosis Treatment, by Diagnostic Tests USD Million (2018-2023)
  • Table 159. Mexico Halitosis Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 160. Mexico Halitosis Treatment, by Drug Treatment USD Million (2018-2023)
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Halitosis Treatment: by Type(USD Million)
  • Table 171. Halitosis Treatment Pathological , by Region USD Million (2024-2029)
  • Table 172. Halitosis Treatment Non-pathological , by Region USD Million (2024-2029)
  • Table 173. Halitosis Treatment: by Application(USD Million)
  • Table 174. Halitosis Treatment Lungs , by Region USD Million (2024-2029)
  • Table 175. Halitosis Treatment Liver , by Region USD Million (2024-2029)
  • Table 176. Halitosis Treatment Respiratory , by Region USD Million (2024-2029)
  • Table 177. Halitosis Treatment Systemic , by Region USD Million (2024-2029)
  • Table 178. Halitosis Treatment Gastrointestinal , by Region USD Million (2024-2029)
  • Table 179. Halitosis Treatment Others , by Region USD Million (2024-2029)
  • Table 180. Halitosis Treatment: by Diagnostic Tests(USD Million)
  • Table 181. Halitosis Treatment Gas chromatography , by Region USD Million (2024-2029)
  • Table 182. Halitosis Treatment Halimeter , by Region USD Million (2024-2029)
  • Table 183. Halitosis Treatment Beta-galactosidase activity assay , by Region USD Million (2024-2029)
  • Table 184. Halitosis Treatment Others , by Region USD Million (2024-2029)
  • Table 185. Halitosis Treatment: by Distribution Channel(USD Million)
  • Table 186. Halitosis Treatment Dental Hospitals , by Region USD Million (2024-2029)
  • Table 187. Halitosis Treatment Dental Clinics , by Region USD Million (2024-2029)
  • Table 188. Halitosis Treatment Retail Pharmacies , by Region USD Million (2024-2029)
  • Table 189. Halitosis Treatment Online Pharmacies , by Region USD Million (2024-2029)
  • Table 190. Halitosis Treatment: by Drug Treatment(USD Million)
  • Table 191. Halitosis Treatment Antiseptic , by Region USD Million (2024-2029)
  • Table 192. Halitosis Treatment Antacids , by Region USD Million (2024-2029)
  • Table 193. Halitosis Treatment Ranitidine , by Region USD Million (2024-2029)
  • Table 194. Halitosis Treatment Others , by Region USD Million (2024-2029)
  • Table 195. South America Halitosis Treatment, by Country USD Million (2024-2029)
  • Table 196. South America Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 197. South America Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 198. South America Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 199. South America Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 200. South America Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 201. Brazil Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 202. Brazil Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 203. Brazil Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 204. Brazil Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 205. Brazil Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 206. Argentina Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 207. Argentina Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 208. Argentina Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 209. Argentina Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 210. Argentina Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 211. Rest of South America Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 212. Rest of South America Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 213. Rest of South America Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 214. Rest of South America Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 215. Rest of South America Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 216. Asia Pacific Halitosis Treatment, by Country USD Million (2024-2029)
  • Table 217. Asia Pacific Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 218. Asia Pacific Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 219. Asia Pacific Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 220. Asia Pacific Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 221. Asia Pacific Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 222. China Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 223. China Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 224. China Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 225. China Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 226. China Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 227. Japan Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 228. Japan Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 229. Japan Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 230. Japan Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 231. Japan Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 232. India Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 233. India Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 234. India Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 235. India Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 236. India Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 237. South Korea Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 238. South Korea Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 239. South Korea Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 240. South Korea Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 241. South Korea Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 242. Taiwan Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 243. Taiwan Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 244. Taiwan Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 245. Taiwan Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 246. Taiwan Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 247. Australia Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 248. Australia Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 249. Australia Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 250. Australia Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 251. Australia Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 252. Rest of Asia-Pacific Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 253. Rest of Asia-Pacific Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 254. Rest of Asia-Pacific Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 255. Rest of Asia-Pacific Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 256. Rest of Asia-Pacific Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 257. Europe Halitosis Treatment, by Country USD Million (2024-2029)
  • Table 258. Europe Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 259. Europe Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 260. Europe Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 261. Europe Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 262. Europe Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 263. Germany Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 264. Germany Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 265. Germany Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 266. Germany Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 267. Germany Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 268. France Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 269. France Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 270. France Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 271. France Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 272. France Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 273. Italy Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 274. Italy Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 275. Italy Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 276. Italy Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 277. Italy Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 278. United Kingdom Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 279. United Kingdom Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 280. United Kingdom Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 281. United Kingdom Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 282. United Kingdom Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 283. Netherlands Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 284. Netherlands Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 285. Netherlands Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 286. Netherlands Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 287. Netherlands Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 288. Rest of Europe Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 289. Rest of Europe Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 290. Rest of Europe Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 291. Rest of Europe Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 292. Rest of Europe Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 293. MEA Halitosis Treatment, by Country USD Million (2024-2029)
  • Table 294. MEA Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 295. MEA Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 296. MEA Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 297. MEA Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 298. MEA Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 299. Middle East Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 300. Middle East Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 301. Middle East Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 302. Middle East Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 303. Middle East Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 304. Africa Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 305. Africa Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 306. Africa Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 307. Africa Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 308. Africa Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 309. North America Halitosis Treatment, by Country USD Million (2024-2029)
  • Table 310. North America Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 311. North America Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 312. North America Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 313. North America Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 314. North America Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 315. United States Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 316. United States Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 317. United States Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 318. United States Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 319. United States Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 320. Canada Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 321. Canada Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 322. Canada Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 323. Canada Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 324. Canada Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 325. Mexico Halitosis Treatment, by Type USD Million (2024-2029)
  • Table 326. Mexico Halitosis Treatment, by Application USD Million (2024-2029)
  • Table 327. Mexico Halitosis Treatment, by Diagnostic Tests USD Million (2024-2029)
  • Table 328. Mexico Halitosis Treatment, by Distribution Channel USD Million (2024-2029)
  • Table 329. Mexico Halitosis Treatment, by Drug Treatment USD Million (2024-2029)
  • Table 330. Research Programs/Design for This Report
  • Table 331. Key Data Information from Secondary Sources
  • Table 332. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Halitosis Treatment: by Type USD Million (2018-2023)
  • Figure 5. Global Halitosis Treatment: by Application USD Million (2018-2023)
  • Figure 6. Global Halitosis Treatment: by Diagnostic Tests USD Million (2018-2023)
  • Figure 7. Global Halitosis Treatment: by Distribution Channel USD Million (2018-2023)
  • Figure 8. Global Halitosis Treatment: by Drug Treatment USD Million (2018-2023)
  • Figure 9. South America Halitosis Treatment Share (%), by Country
  • Figure 10. Asia Pacific Halitosis Treatment Share (%), by Country
  • Figure 11. Europe Halitosis Treatment Share (%), by Country
  • Figure 12. MEA Halitosis Treatment Share (%), by Country
  • Figure 13. North America Halitosis Treatment Share (%), by Country
  • Figure 14. Global Halitosis Treatment share by Players 2023 (%)
  • Figure 15. Global Halitosis Treatment share by Players (Top 3) 2023(%)
  • Figure 16. Global Halitosis Treatment share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Colgate-Palmolive Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Colgate-Palmolive Company (United States) Revenue: by Geography 2023
  • Figure 20. All USA Partners LLC (United States) Revenue, Net Income and Gross profit
  • Figure 21. All USA Partners LLC (United States) Revenue: by Geography 2023
  • Figure 22. Dr. Harold Katz, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 23. Dr. Harold Katz, LLC (United States) Revenue: by Geography 2023
  • Figure 24. Listerine (United States) Revenue, Net Income and Gross profit
  • Figure 25. Listerine (United States) Revenue: by Geography 2023
  • Figure 26. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. AstraZeneca (United Kingdom) Revenue: by Geography 2023
  • Figure 28. Unilever (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Unilever (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Oral B (United States) Revenue, Net Income and Gross profit
  • Figure 31. Oral B (United States) Revenue: by Geography 2023
  • Figure 32. Philips oral healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 33. Philips oral healthcare (United States) Revenue: by Geography 2023
  • Figure 34. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Roche (Switzerland) Revenue: by Geography 2023
  • Figure 36. Global Halitosis Treatment: by Type USD Million (2024-2029)
  • Figure 37. Global Halitosis Treatment: by Application USD Million (2024-2029)
  • Figure 38. Global Halitosis Treatment: by Diagnostic Tests USD Million (2024-2029)
  • Figure 39. Global Halitosis Treatment: by Distribution Channel USD Million (2024-2029)
  • Figure 40. Global Halitosis Treatment: by Drug Treatment USD Million (2024-2029)
  • Figure 41. South America Halitosis Treatment Share (%), by Country
  • Figure 42. Asia Pacific Halitosis Treatment Share (%), by Country
  • Figure 43. Europe Halitosis Treatment Share (%), by Country
  • Figure 44. MEA Halitosis Treatment Share (%), by Country
  • Figure 45. North America Halitosis Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Colgate-Palmolive Company (United States)
  • All USA Partners LLC (United States)
  • Dr. Harold Katz, LLC (United States)
  • Listerine (United States)
  • AstraZeneca (United Kingdom)
  • Unilever (United Kingdom)
  • Oral B (United States)
  • Philips oral healthcare (United States)
  • Roche (Switzerland)
Additional players considered in the study are as follows:
Rowpar Pharmaceuticals, Inc. (United States) , Dabur (India)
Select User Access Type

Key Highlights of Report


Jan 2024 250 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Halitosis Treatment Quantitative research analysis
Global Halitosis Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Halitosis Treatment Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global Halitosis Treatment market is dominated by United States Players and may generate healthy valuation by 2029.
  • Increasing Incidents of Dental Problems
  • Surge in Geriatric Population Suffering From These Diseases
dominated the Halitosis Treatment market. This is attributable to growing trend of "Growing Use of Various Oral Care Products Such As Mouth Washes, Toothpastes, and Mouth Sprays"

Know More About Global Halitosis Treatment Report?

Have a Query? Click Here

Other Related Reports

Circulating Tumor Cells (CTC) Comprehensive Study by Type (Ex-Vivo Positive Selection, In-Vivo Positive Selection, Negative Selection, Microchips & Single Spiral Micro Channel), Application (Tumorige...
$ 3450
Sleep Disorder Therapeutics Comprehensive Study by Type (Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Others), Medical Devices) Players and ...
$ 3500
Shingles Treatments Comprehensive Study by Type (Antiviral Medications, Narcotic Medications, Anti-Inflammatory Medications, Antihistamines, Anticonvulsants, Creams, Others), Route of Administration ...
$ 3450
Schizophrenia Treatments Comprehensive Study by Type (Medications, Conventional or Typical Antipsychotic Drugs, Atypical Antipsychotic Drugs, Therapies), End Users (Hospital Pharmacies, Drug Stores, ...
$ 3650
Sarcopenia Treatment Comprehensive Study by Type (Protein Supplement, Vitamin B12 Supplement, Vitamin D & Calcium Supplement, Others), End-users (Hospitals, Clinics, Others), Distribution Channel (Ho...
$ 3350
Critical Limb Ischemia Treatment Comprehensive Study by Type (Medications (Antiplatelet Drugs, Antihypertensive Agents, Lipid-lowering Agents, Others), Endovascular Treatments, Surgery), Application ...
$ 3450